111 Capital’s MetLife MET Stock Holding History

111 Capital’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,016	Closed	-$317K	–	409
2025 Q4	$317K	Buy	+4,016	New	+$318K	0.07%	219
2025 Q3	–	Sell	-13,683	Closed	-$1.1M	–	605
2025 Q2	$1.1M	Buy	13,683 +7,688	+128%	+$593K	0.19%	120
2025 Q1	$481K	Buy	+5,995	New	+$499K	0.09%	229

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

111 Capital's MET Position: Q1 2026 in Review

111 Capital sold out of MetLife (MET) in Q1 2026, closing a stake of 4,016 shares — an estimated $317K sold.

111 Capital first reported a position in MET in Q1 2025 and held it in 3 quarters. The position peaked at $1.1M in Q2 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

111 Capital reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
111 Capital sold 4,016 MetLife shares in Q1 2026, an estimated $317K.
111 Capital first reported a position in MetLife in Q1 2025 and held it in 3 quarters.
111 Capital's MetLife position peaked at $1.1M in Q2 2025.
1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on 111 Capital's 13F filing for Q1 2026, filed 11 May 2026.